Charles Schwab Investment Management Inc Gossamer Bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,261,597 shares of GOSS stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,261,597
Previous 1,252,764
0.71%
Holding current value
$1.21 Million
Previous $1.48 Million
23.21%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding GOSS
# of Institutions
101Shares Held
175MCall Options Held
453KPut Options Held
543K-
Nea Management Company, LLC Timonium, MD18.1MShares$17.4 Million1.54% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$12.8 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$11.3 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.82 Million1.91% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$7.73 Million4.25% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $90.2M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...